NCT01005628
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Seoul, South Korea
Clinical trial condition
Hemostatic Disorders
Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.
3,075 public trials
581 recruiting studies
Hemostatic Disorders trial results
NCT00002750
- Conditions
- Adnexal Diseases, Blood Protein Disorders, Brain and Central Nervous System Tumors, +66 more
- Locations
-
- Duke Comprehensive Cancer Center Durham, North Carolina, United States
NCT00823524
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
- Locations
-
- University of Ulsan, Asan Medical Center Seoul, South Korea
NCT00741377
- Conditions
- Blood Protein Disorders, Bone Diseases, Cardiovascular Diseases, +15 more
- Locations
-
- Mayo Clinic - Arizona Cancer Clinical Research Unit Scottsdale, Arizona, United States
- Highlands Oncology Group Dept of Highlands Oncology Grp Fayetteville, Arkansas, United States
- Dana Farber Cancer Institute Deptof DanaFarberCancerInst(2) Boston, Massachusetts, United States
- MD Anderson Cancer Center/University of Texas Dept. of MD Anderson (11) Houston, Texas, United States
NCT01074060
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- City of Hope Duarte, California, United States
NCT00002980
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +84 more
- Locations
-
- Beckman Research Institute, City of Hope Duarte, California, United States
- USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
- Los Angeles County-University of Southern California Medical Center Los Angeles, California, United States
- University of California Davis Cancer Center Sacramento, California, United States
NCT00962507
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +49 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- City of Hope Medical Group Pasadena, California, United States
NCT00002745
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
- Locations
-
- Walter Reed Army Medical Center Washington D.C., District of Columbia, United States
- University of Minnesota Cancer Center Minneapolis, Minnesota, United States
- Washington University Barnard Cancer Center St Louis, Missouri, United States
- Cooper Cancer Institute Camden, New Jersey, United States
NCT00005967
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +68 more
- Locations
-
- University of Chicago Cancer Research Center Chicago, Illinois, United States
Completed
Vorinostat and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT00310024
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States